| Dr Sylvan Brown, MD | |
|
1245 S Cedar Crest Blvd, Suite 203, Allentown, PA 18103-6258 | |
| (610) 435-2423 | |
| (610) 435-8471 |
| Full Name | Dr Sylvan Brown |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 1245 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992787170 | NPI | - | NPPES |
| 110212447 | Other | RR MEDICARE | |
| 01556501 | Other | CBC | |
| 0036953000 | Other | IBC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD013392E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sylvan Brown, MD 1901 W Hamilton St, Suite 100b, Allentown, PA 18104-6459 Ph: (610) 973-1410 | Dr Sylvan Brown, MD 1245 S Cedar Crest Blvd, Suite 203, Allentown, PA 18103-6258 Ph: (610) 435-2423 |
News Archive
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that it has received commitments from certain investors to purchase approximately $7 million of previously unissued securities in a registered direct offering. The investors include the Chairman and CEO, Alnoor Shivji, who has agreed to purchase $1 million of securities in the registered direct offering.
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the year ended December 31, 2015.
Huntington's disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put a stop to the insidious disintegration of brain cells.
› Verified 8 days ago
Jessica Mary Boehmler, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Allison Jane Baragona, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Dr. Ian William Klansek, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2490 Schoenersville Rd, Allentown, PA 18109 Phone: 484-526-7262 |